The prevalence of Sjogren's syndrome in adult women

Articles > Article · 2006

Authors: Yasemin KABASAKAL, Gül Kitapçıoğlu, T. Turk, Gonca KARABULUT, İsabel Raika DURUSOY, Emine Nihal METE GÖKMEN, S. Eğrilmez, Taner AKALIN

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, Journal Indexed in SCI Expanded, International, 2006, vol 35, pp 379-383

DOI: 10.1080/03009740600759704

Summary

<p>Objectives:&nbsp;The&nbsp;aim&nbsp;of&nbsp;this study was to determine&nbsp;the&nbsp;prevalence&nbsp;of&nbsp;primary&nbsp;Sjogren's&nbsp;syndrome&nbsp;(pSS) according to European criteria (1993) and to&nbsp;the&nbsp;US-European Consensus Group (US-EU) criteria (2002)&nbsp;in&nbsp;adult&nbsp;women&nbsp;in&nbsp;Bornova, Izmir, Turkey.</p><p>Materials and method:&nbsp;The&nbsp;study was designed as a two-phase cross-sectional survey consisting&nbsp;of&nbsp;a baseline questionnaire and collection&nbsp;of&nbsp;blood samples and clinical examination.&nbsp;In&nbsp;the&nbsp;initial phase, positivity for autoantibodies Ro(SS-A), La(SS-B), rheumatoid factor (RF), and anti-nuclear antibodies (ANA) was determined, and&nbsp;in&nbsp;the&nbsp;clinical phase, clinical examination, salivary and ocular tests were performed. Minor salivary gland biopsy was performed for those who had at least three&nbsp;of&nbsp;these five criteria positive.</p><p>Results:&nbsp;In&nbsp;our sample&nbsp;the&nbsp;prevalence&nbsp;of&nbsp;SS was 1.56% [95% confidence interval (CI) 0.92-2.66] according to&nbsp;the&nbsp;European criteria and 0.72% (95% CI 0.33-1.57) according to&nbsp;the&nbsp;US-EU criteria.</p><p>Conclusion: To prevent&nbsp;the&nbsp;loss&nbsp;in&nbsp;diagnosis&nbsp;of&nbsp;pSS,&nbsp;the&nbsp;addition&nbsp;of&nbsp;ANA, RF, and tear break-up time (BUT) tests to US-EU criteria would be appropriate.</p>

View details